Infection Surveillance Solutions Market Size, Share and Growth Outlook 2026: By Component (Software, Services), By Deployment Mode, By End-User, Companies to 2034
The global Infection Surveillance Solutions Market size is forecast to increase from $782.11 Million in 2026 to $2021.04 Million in 2034 at a CAGR of 12.6% between 2026 and 2034.
The Infection Surveillance Solutions market report provides detailed analysis and outlook of Infection Surveillance Solutions segments including By Component (Software, Services), By Deployment Mode (On-Premise, Web-Based/Cloud-Based), By End-User (Hospitals, Long-term Care Facilities, Nursing Homes, Homecare Agencies and Hospices, Assisted Living Facilities, Ambulatory Care Centers, Academic Institutes, Others) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Infection Surveillance Solutions Industry Overview
Digital Transformation Accelerating Infection Surveillance Modernization
The infection surveillance solutions industry is experiencing rapid evolution as healthcare systems increasingly adopt digital technologies to improve infection prevention, regulatory compliance, and patient safety outcomes. Rising concerns regarding healthcare-associated infections, antimicrobial resistance, and hospital-acquired complications are driving healthcare organizations to invest in advanced surveillance platforms capable of collecting, analyzing, and interpreting large volumes of clinical data. Modern infection surveillance systems are moving beyond manual reporting processes toward automated, real-time monitoring environments that support faster identification of emerging infection risks and more consistent reporting across healthcare networks.
Centralized Surveillance Models Strengthening Healthcare Network Oversight
A significant trend shaping the industry is the growing adoption of centralized infection surveillance frameworks that enable standardized monitoring across multiple healthcare facilities. The Association for Professionals in Infection Control and Epidemiology introduced a comprehensive framework and white paper focused on centralized healthcare-associated infection surveillance programs within acute care systems. The initiative establishes guidance for digital platforms to aggregate data from multiple facilities, standardize reporting methodologies, and improve interrater consistency in regulatory reporting. The introduction of a specialized micro-credential further highlights the increasing emphasis on workforce competency and standardized infection prevention practices. These developments are encouraging healthcare organizations to implement enterprise-wide surveillance strategies that improve visibility across integrated care networks.
Artificial Intelligence and Clinical Algorithms Enhancing Early Detection
Advanced analytics and automated clinical intelligence are becoming central components of modern infection surveillance platforms. Healthcare providers are increasingly seeking solutions capable of identifying infection patterns before they escalate into larger outbreaks. Wolters Kluwer enhanced its POC Advisor platform with sophisticated clinical surveillance capabilities that leverage localized patient data processing and advanced algorithms within electronic health record environments. The system continuously evaluates patient information to identify early indicators of hospital-acquired infections and severe sepsis, enabling healthcare teams to intervene more rapidly. Such innovations demonstrate the growing role of predictive analytics and automated monitoring in improving clinical decision-making and infection control performance.
Regulatory Compliance and Data Integration Driving Market Growth
The industry is also benefiting from increasing regulatory requirements related to infection reporting, quality metrics, and patient safety initiatives. Healthcare facilities are under growing pressure to maintain accurate surveillance records while managing large and complex datasets across multiple departments and locations. As a result, demand is increasing for integrated surveillance platforms that connect seamlessly with electronic health records, laboratory information systems, and clinical reporting tools. The convergence of centralized data management, automated reporting algorithms, and real-time infection monitoring is positioning infection surveillance solutions as essential infrastructure for modern healthcare organizations seeking to improve operational efficiency, regulatory compliance, and infection prevention outcomes.
Infection Surveillance Solutions Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Infection Surveillance Solutions market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Becton, Dickinson and Company, Oracle Corporation, Inovalon, Premier, Inc., Wolters Kluwer N.V., RLDatix, Baxter International Inc. , Gojo Industries, Inc., Craneware plc, IBM Corporation. The Infection Surveillance Solutions market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Infection Surveillance Solutions industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Infection Surveillance Solutions industry include- Becton, Dickinson and Company, Oracle Corporation, Inovalon, Premier, Inc., Wolters Kluwer N.V., RLDatix, Baxter International Inc. , Gojo Industries, Inc., Craneware plc, IBM Corporation. The Infection Surveillance Solutions market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Infection Surveillance Solutions Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Infection Surveillance Solutions market remains one of the strongest-performing segments in the country.
The US Infection Surveillance Solutions Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Infection Surveillance Solutions market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Infection Surveillance Solutions industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Infection Surveillance Solutions markets
Canada's strong Infection Surveillance Solutions sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Infection Surveillance Solutions market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Infection Surveillance Solutions Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Infection Surveillance Solutions market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Infection Surveillance Solutions population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Infection Surveillance Solutions industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Infection Surveillance Solutions market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Infection Surveillance Solutions sales through 2034
France Infection Surveillance Solutions companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Infection Surveillance Solutions Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Infection Surveillance Solutions distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Infection Surveillance Solutions Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Infection Surveillance Solutions market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Infection Surveillance Solutions industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Infection Surveillance Solutions industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Infection Surveillance Solutions Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Infection Surveillance Solutions market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Infection Surveillance Solutions market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Infection Surveillance Solutions Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Infection Surveillance Solutions Market Segmentation
By Component
Software
Services
By Deployment Mode
On-Premise
Web-Based/Cloud-Based
By End-User
Hospitals
Long-term Care Facilities
Nursing Homes
Homecare Agencies and Hospices
Assisted Living Facilities
Ambulatory Care Centers
Academic Institutes
Others
Leading Companies in Infection Surveillance Solutions Industry (2026)
Becton, Dickinson and Company
Oracle Corporation
Inovalon
Premier, Inc.
Wolters Kluwer N.V.
RLDatix
Baxter International Inc.
Gojo Industries, Inc.
Craneware plc
IBM Corporation
Countries Included
The Infection Surveillance Solutions market report provides detailed analysis and outlook of Infection Surveillance Solutions segments including By Component (Software, Services), By Deployment Mode (On-Premise, Web-Based/Cloud-Based), By End-User (Hospitals, Long-term Care Facilities, Nursing Homes, Homecare Agencies and Hospices, Assisted Living Facilities, Ambulatory Care Centers, Academic Institutes, Others) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Infection Surveillance Solutions Industry Overview
Digital Transformation Accelerating Infection Surveillance Modernization
The infection surveillance solutions industry is experiencing rapid evolution as healthcare systems increasingly adopt digital technologies to improve infection prevention, regulatory compliance, and patient safety outcomes. Rising concerns regarding healthcare-associated infections, antimicrobial resistance, and hospital-acquired complications are driving healthcare organizations to invest in advanced surveillance platforms capable of collecting, analyzing, and interpreting large volumes of clinical data. Modern infection surveillance systems are moving beyond manual reporting processes toward automated, real-time monitoring environments that support faster identification of emerging infection risks and more consistent reporting across healthcare networks.
Centralized Surveillance Models Strengthening Healthcare Network Oversight
A significant trend shaping the industry is the growing adoption of centralized infection surveillance frameworks that enable standardized monitoring across multiple healthcare facilities. The Association for Professionals in Infection Control and Epidemiology introduced a comprehensive framework and white paper focused on centralized healthcare-associated infection surveillance programs within acute care systems. The initiative establishes guidance for digital platforms to aggregate data from multiple facilities, standardize reporting methodologies, and improve interrater consistency in regulatory reporting. The introduction of a specialized micro-credential further highlights the increasing emphasis on workforce competency and standardized infection prevention practices. These developments are encouraging healthcare organizations to implement enterprise-wide surveillance strategies that improve visibility across integrated care networks.
Artificial Intelligence and Clinical Algorithms Enhancing Early Detection
Advanced analytics and automated clinical intelligence are becoming central components of modern infection surveillance platforms. Healthcare providers are increasingly seeking solutions capable of identifying infection patterns before they escalate into larger outbreaks. Wolters Kluwer enhanced its POC Advisor platform with sophisticated clinical surveillance capabilities that leverage localized patient data processing and advanced algorithms within electronic health record environments. The system continuously evaluates patient information to identify early indicators of hospital-acquired infections and severe sepsis, enabling healthcare teams to intervene more rapidly. Such innovations demonstrate the growing role of predictive analytics and automated monitoring in improving clinical decision-making and infection control performance.
Regulatory Compliance and Data Integration Driving Market Growth
The industry is also benefiting from increasing regulatory requirements related to infection reporting, quality metrics, and patient safety initiatives. Healthcare facilities are under growing pressure to maintain accurate surveillance records while managing large and complex datasets across multiple departments and locations. As a result, demand is increasing for integrated surveillance platforms that connect seamlessly with electronic health records, laboratory information systems, and clinical reporting tools. The convergence of centralized data management, automated reporting algorithms, and real-time infection monitoring is positioning infection surveillance solutions as essential infrastructure for modern healthcare organizations seeking to improve operational efficiency, regulatory compliance, and infection prevention outcomes.
Infection Surveillance Solutions Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Infection Surveillance Solutions market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Becton, Dickinson and Company, Oracle Corporation, Inovalon, Premier, Inc., Wolters Kluwer N.V., RLDatix, Baxter International Inc. , Gojo Industries, Inc., Craneware plc, IBM Corporation. The Infection Surveillance Solutions market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Infection Surveillance Solutions industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Infection Surveillance Solutions Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Infection Surveillance Solutions companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Infection Surveillance Solutions markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Infection Surveillance Solutions industry include- Becton, Dickinson and Company, Oracle Corporation, Inovalon, Premier, Inc., Wolters Kluwer N.V., RLDatix, Baxter International Inc. , Gojo Industries, Inc., Craneware plc, IBM Corporation. The Infection Surveillance Solutions market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Infection Surveillance Solutions Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Infection Surveillance Solutions market remains one of the strongest-performing segments in the country.
The US Infection Surveillance Solutions Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Infection Surveillance Solutions market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Infection Surveillance Solutions industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Infection Surveillance Solutions markets
Canada's strong Infection Surveillance Solutions sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Infection Surveillance Solutions market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Infection Surveillance Solutions Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Infection Surveillance Solutions market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Infection Surveillance Solutions population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Infection Surveillance Solutions industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Infection Surveillance Solutions market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Infection Surveillance Solutions sales through 2034
France Infection Surveillance Solutions companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Infection Surveillance Solutions Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Infection Surveillance Solutions distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Infection Surveillance Solutions Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Infection Surveillance Solutions market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Infection Surveillance Solutions industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Infection Surveillance Solutions industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Infection Surveillance Solutions Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Infection Surveillance Solutions market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Infection Surveillance Solutions market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Infection Surveillance Solutions Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Infection Surveillance Solutions Market Segmentation
By Component
Software
Services
By Deployment Mode
On-Premise
Web-Based/Cloud-Based
By End-User
Hospitals
Long-term Care Facilities
Nursing Homes
Homecare Agencies and Hospices
Assisted Living Facilities
Ambulatory Care Centers
Academic Institutes
Others
Leading Companies in Infection Surveillance Solutions Industry (2026)
Becton, Dickinson and Company
Oracle Corporation
Inovalon
Premier, Inc.
Wolters Kluwer N.V.
RLDatix
Baxter International Inc.
Gojo Industries, Inc.
Craneware plc
IBM Corporation
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Infection Surveillance Solutions Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Infection Surveillance Solutions Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Infection Surveillance Solutions Markets in 2026
3.2. Global Historic and Forecast Infection Surveillance Solutions Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Infection Surveillance Solutions Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Infection Surveillance Solutions Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Infection Surveillance Solutions Value Chain
CHAPTER 4- INFECTION SURVEILLANCE SOLUTIONS MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Infection Surveillance Solutions Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- INFECTION SURVEILLANCE SOLUTIONS MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Component
Software
Services
By Deployment Mode
On-Premise
Web-Based/Cloud-Based
By End-User
Hospitals
Long-term Care Facilities
Nursing Homes
Homecare Agencies and Hospices
Assisted Living Facilities
Ambulatory Care Centers
Academic Institutes
Others
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Infection Surveillance Solutions Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Infection Surveillance Solutions Market Trends and Growth Opportunities to 2034
7.5. North America Infection Surveillance Solutions Market Size Outlook by Type
7.6. North America Infection Surveillance Solutions Market Size Outlook by Application
7.7. North America Infection Surveillance Solutions Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Infection Surveillance Solutions Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Infection Surveillance Solutions Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Infection Surveillance Solutions Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Infection Surveillance Solutions Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Infection Surveillance Solutions Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Infection Surveillance Solutions Companies
CHAPTER 8- EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Infection Surveillance Solutions Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Infection Surveillance Solutions Market Trends and Growth Opportunities to 2034
8.5. Europe Infection Surveillance Solutions Market Size Outlook by Type
8.6. Europe Infection Surveillance Solutions Market Size Outlook by Application
8.7. Europe Infection Surveillance Solutions Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Infection Surveillance Solutions Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Infection Surveillance Solutions Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Infection Surveillance Solutions Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Infection Surveillance Solutions Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Infection Surveillance Solutions Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Infection Surveillance Solutions Companies
CHAPTER 9- ASIA PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Infection Surveillance Solutions Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Infection Surveillance Solutions Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Infection Surveillance Solutions Market Size Outlook by Type
9.6. Asia Pacific Infection Surveillance Solutions Market Size Outlook by Application
9.7. Asia Pacific Infection Surveillance Solutions Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Infection Surveillance Solutions Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Infection Surveillance Solutions Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Infection Surveillance Solutions Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Infection Surveillance Solutions Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Infection Surveillance Solutions Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Infection Surveillance Solutions Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Infection Surveillance Solutions Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Infection Surveillance Solutions Market Trends and Growth Opportunities to 2034
10.5. South and Central America Infection Surveillance Solutions Market Size Outlook by Type
10.6. South and Central America Infection Surveillance Solutions Market Size Outlook by Application
10.7. South and Central America Infection Surveillance Solutions Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Infection Surveillance Solutions Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Infection Surveillance Solutions Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Infection Surveillance Solutions Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Infection Surveillance Solutions Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Infection Surveillance Solutions Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Infection Surveillance Solutions Companies
CHAPTER 11- MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Infection Surveillance Solutions Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Infection Surveillance Solutions Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Infection Surveillance Solutions Market Size Outlook by Type
11.6. Middle East and Africa Infection Surveillance Solutions Market Size Outlook by Application
11.7. Middle East and Africa Infection Surveillance Solutions Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Infection Surveillance Solutions Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Infection Surveillance Solutions Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Infection Surveillance Solutions Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Infection Surveillance Solutions Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Infection Surveillance Solutions Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Infection Surveillance Solutions Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Infection Surveillance Solutions Industry
Becton, Dickinson and Company
Oracle Corporation
Inovalon
Premier, Inc.
Wolters Kluwer N.V.
RLDatix
Baxter International Inc.
Gojo Industries, Inc.
Craneware plc
IBM Corporation
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Infection Surveillance Solutions Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Infection Surveillance Solutions Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Infection Surveillance Solutions Markets in 2026
3.2. Global Historic and Forecast Infection Surveillance Solutions Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Infection Surveillance Solutions Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Infection Surveillance Solutions Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Infection Surveillance Solutions Value Chain
CHAPTER 4- INFECTION SURVEILLANCE SOLUTIONS MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Infection Surveillance Solutions Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- INFECTION SURVEILLANCE SOLUTIONS MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Component
Software
Services
By Deployment Mode
On-Premise
Web-Based/Cloud-Based
By End-User
Hospitals
Long-term Care Facilities
Nursing Homes
Homecare Agencies and Hospices
Assisted Living Facilities
Ambulatory Care Centers
Academic Institutes
Others
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Infection Surveillance Solutions Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Infection Surveillance Solutions Market Trends and Growth Opportunities to 2034
7.5. North America Infection Surveillance Solutions Market Size Outlook by Type
7.6. North America Infection Surveillance Solutions Market Size Outlook by Application
7.7. North America Infection Surveillance Solutions Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Infection Surveillance Solutions Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Infection Surveillance Solutions Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Infection Surveillance Solutions Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Infection Surveillance Solutions Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Infection Surveillance Solutions Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Infection Surveillance Solutions Companies
CHAPTER 8- EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Infection Surveillance Solutions Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Infection Surveillance Solutions Market Trends and Growth Opportunities to 2034
8.5. Europe Infection Surveillance Solutions Market Size Outlook by Type
8.6. Europe Infection Surveillance Solutions Market Size Outlook by Application
8.7. Europe Infection Surveillance Solutions Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Infection Surveillance Solutions Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Infection Surveillance Solutions Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Infection Surveillance Solutions Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Infection Surveillance Solutions Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Infection Surveillance Solutions Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Infection Surveillance Solutions Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Infection Surveillance Solutions Companies
CHAPTER 9- ASIA PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Infection Surveillance Solutions Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Infection Surveillance Solutions Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Infection Surveillance Solutions Market Size Outlook by Type
9.6. Asia Pacific Infection Surveillance Solutions Market Size Outlook by Application
9.7. Asia Pacific Infection Surveillance Solutions Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Infection Surveillance Solutions Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Infection Surveillance Solutions Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Infection Surveillance Solutions Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Infection Surveillance Solutions Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Infection Surveillance Solutions Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Infection Surveillance Solutions Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Infection Surveillance Solutions Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Infection Surveillance Solutions Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Infection Surveillance Solutions Market Trends and Growth Opportunities to 2034
10.5. South and Central America Infection Surveillance Solutions Market Size Outlook by Type
10.6. South and Central America Infection Surveillance Solutions Market Size Outlook by Application
10.7. South and Central America Infection Surveillance Solutions Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Infection Surveillance Solutions Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Infection Surveillance Solutions Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Infection Surveillance Solutions Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Infection Surveillance Solutions Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Infection Surveillance Solutions Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Infection Surveillance Solutions Companies
CHAPTER 11- MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Infection Surveillance Solutions Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Infection Surveillance Solutions Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Infection Surveillance Solutions Market Size Outlook by Type
11.6. Middle East and Africa Infection Surveillance Solutions Market Size Outlook by Application
11.7. Middle East and Africa Infection Surveillance Solutions Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Infection Surveillance Solutions Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Infection Surveillance Solutions Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Infection Surveillance Solutions Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Infection Surveillance Solutions Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Infection Surveillance Solutions Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Infection Surveillance Solutions Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Infection Surveillance Solutions Industry
Becton, Dickinson and Company
Oracle Corporation
Inovalon
Premier, Inc.
Wolters Kluwer N.V.
RLDatix
Baxter International Inc.
Gojo Industries, Inc.
Craneware plc
IBM Corporation
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
